New serum markers for predicting esophageal varices: Is it a reality?

angiotensin II, carbon monoxide, CD163 antigen, endocannabinoid, endothelin, glucagon, heme oxygenase 1, nitric oxide, noradrenalin, prostaglandin H2, soluble CD163 antigen, unclassified drug, vasculotropin, vasculotropin receptor 2, vasopressin, angiogenesis, ascites, blood vessel reactivity, blood vessel tone, chronic liver disease, decompensated liver cirrhosis, digestive tract endoscopy, editorial, elastography, endothelial dysfunction, esophagus varices, fibrogenesis, genetic polymorphism, genetic risk, genetic variability, genotype, haplotype, hemodynamics, hepatic encephalopathy, hepatitis, hepatopulmonary syndrome, human, Kupffer cell, liver blood flow, pathophysiology, portal hypertension, portal vein blood flow, portal vein blood pressure, predictive value, pressure gradient, priority journal, spleen size, splenomegaly, thrombocyte count, vascular resistance, vein diameter, Biological Markers, Esophageal and Gastric Varices, Gastrointestinal Hemorrhage, Humans, Hypertension, Portal